Swiss Footcare Laboratories sarl

Swiss Footcare Laboratories sarl specializes in topical serums and treatments for foot and nail conditions. Their portfolio includes pipette-formulated antifungal serums, booster serums, night-time intensive treatments, and stylus applicators designed to target fungal nail infections and ingrown toenails. These products are formulated for localized application and are intended to address common nail and foot pathologies without requiring surgical or invasive procedures.

Swiss Footcare Laboratories sarl is based in Switzerland, which means its devices comply with Swiss and EU medical device regulations. Since the company’s products fall under Class I classification in the EU, they are considered low-risk and do not require rigorous clinical evaluation or active medical intervention. This classification aligns with the manufacturer’s focus on non-invasive, over-the-counter treatments for fungal and nail-related conditions.

Yes, Swiss Footcare Laboratories sarl’s devices are registered in the euDAMED database, which is the official EU registry for medical devices. This listing ensures transparency and traceability for authorized products under the EU Medical Device Regulation (MDR) or Medical Device Directive (MDD), confirming their compliance with EU requirements for Class I devices.

Swiss Footcare Laboratories sarl’s devices are classified as Class I under the EU regulatory framework. This classification applies to low-risk medical devices, such as topical serums and non-invasive treatments for fungal nail infections and ingrown toenails. Class I devices typically require basic conformity assessment procedures, such as self-certification by the manufacturer, rather than extensive clinical trials or third-party involvement.